» Articles » PMID: 34786045

LncRNA TMPO-AS1 Serves As a Sponge for MiR-4731-5p Modulating Breast Cancer Progression Through FOXM1

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2021 Nov 17
PMID 34786045
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the function of IncRNA-TMPO-AS1 in breast cancer (BC) and to further explore its molecular mechanism.

Methods: TMPO-AS1, miR-4731-5p and FOXM1 were quantitatively determined using qRT-PCR. CCK-8 assays, plate cloning experiments, wound healing and Transwell assays, and flow cytometry were used to assess the biological behaviors of BC cells. Dual-luciferase reporter assays were used to assess the interactions between TMPO-AS1 and its downstream targets. The apoptosis and cell cycle-related proteins were quantitatively determined using Western blot.

Results: In the BC tissues and cells, TMPO-AS1 was significantly increased (P<0.05). Functional studies suggest that the knockdown of TMPO-AS1 tremendously restrains tumor cell growth and migration (P<0.05). Mechanically, TMPO-AS1 negatively regulates miR-4731-5p and influences the progression of BC through the miR-4731-5p/FOXM1 axis.

Conclusion: LncRNA TMPO-AS1spongess miR-4731-5p to modulate BC progression through FOXM1.

Citing Articles

Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.

Asfa S, Toy H, Arshinchi Bonab R, Chrousos G, Pavlopoulou A, Geronikolou S Int J Environ Res Public Health. 2023; 20(13).

PMID: 37444135 PMC: 10341845. DOI: 10.3390/ijerph20136288.


A long non-coding RNA with important roles in the carcinogenesis.

Ghafouri-Fard S, Askari A, Hussen B, Taheri M, Mokhtari M Front Cell Dev Biol. 2022; 10:1037149.

PMID: 36467407 PMC: 9709449. DOI: 10.3389/fcell.2022.1037149.


Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel <em>via</em> targeting miR-200b-3p/Bcl-2 axis.

Li J, Kang J, Liu W, Liu J, Pan G, Mao A Eur J Histochem. 2022; 66(4).

PMID: 36281649 PMC: 9667572. DOI: 10.4081/ejh.2022.3529.


miR-4731-5p Enhances Apoptosis and Alleviates Epithelial-Mesenchymal Transition through Targeting RPLP0 in Non-Small-Cell Lung Cancer.

Chang C, Xu M J Oncol. 2022; 2022:3793318.

PMID: 35342398 PMC: 8947863. DOI: 10.1155/2022/3793318.

References
1.
Laoukili J, Stahl M, Medema R . FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta. 2006; 1775(1):92-102. DOI: 10.1016/j.bbcan.2006.08.006. View

2.
Mattick J, Rinn J . Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol. 2015; 22(1):5-7. DOI: 10.1038/nsmb.2942. View

3.
Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R . Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2017; 75(3):467-484. PMC: 5765200. DOI: 10.1007/s00018-017-2626-6. View

4.
Wang B, Wang H, Yang Z . MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS One. 2012; 7(10):e47053. PMC: 3466252. DOI: 10.1371/journal.pone.0047053. View

5.
Autier P, Hery C, Haukka J, Boniol M, Byrnes G . Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009; 27(35):5919-23. DOI: 10.1200/JCO.2009.22.7041. View